We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Human-Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Showed Neuronal Differentiation, Neurite Extension, and Formation of Synaptic Structures in Rodent Ischemic Stroke Brains.
- Authors
Kanemura, Yonehiro; Yamamoto, Atsuyo; Katsuma, Asako; Fukusumi, Hayato; Shofuda, Tomoko; Kanematsu, Daisuke; Handa, Yukako; Sumida, Miho; Yoshioka, Ema; Mine, Yutaka; Yamaguchi, Ryo; Okada, Masayasu; Igarashi, Michihiro; Sekino, Yuko; Shirao, Tomoaki; Nakamura, Masaya; Okano, Hideyuki
- Abstract
Ischemic stroke is a major cerebrovascular disease with high morbidity and mortality rates; however, effective treatments for ischemic stroke-related neurological dysfunction have yet to be developed. In this study, we generated neural progenitor cells from human leukocyte antigen major loci gene-homozygous-induced pluripotent stem cells (hiPSC-NPCs) and evaluated their therapeutic effects against ischemic stroke. hiPSC-NPCs were intracerebrally transplanted into rat ischemic brains produced by transient middle cerebral artery occlusion at either the subacute or acute stage, and their in vivo survival, differentiation, and efficacy for functional improvement in neurological dysfunction were evaluated. hiPSC-NPCs were histologically identified in host brain tissues and showed neuronal differentiation into vGLUT-positive glutamatergic neurons, extended neurites into both the ipsilateral infarct and contralateral healthy hemispheres, and synaptic structures formed 12 weeks after both acute and subacute stage transplantation. They also improved neurological function when transplanted at the subacute stage with γ-secretase inhibitor pretreatment. However, their effects were modest and not significant and showed a possible risk of cells remaining in their undifferentiated and immature status in acute-stage transplantation. These results suggest that hiPSC-NPCs show cell replacement effects in ischemic stroke-damaged neural tissues, but their efficacy is insufficient for neurological functional improvement after acute or subacute transplantation. Further optimization of cell preparation methods and the timing of transplantation is required to balance the efficacy and safety of hiPSC-NPC transplantation.
- Subjects
CEREBRAL arteries; ISCHEMIC stroke; NEURAL stem cells; NEURONAL differentiation; DEVELOPMENTAL neurobiology; PROGENITOR cells; PLURIPOTENT stem cells; HLA histocompatibility antigens
- Publication
Cells (2073-4409), 2024, Vol 13, Issue 8, p671
- ISSN
2073-4409
- Publication type
Article
- DOI
10.3390/cells13080671